Amundi Asset Management US’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $36.2M | Sell |
1,075,160
-1,347,118
| -56% | -$45.4M | 0.03% | 511 |
|
|
2020
Q4 | $84.6M | Buy |
2,422,278
+335,146
| +16% | +$11.7M | 0.07% | 284 |
|
|
2020
Q3 | $72.5M | Buy |
2,087,132
+15,048
| +0.7% | +$522K | 0.08% | 261 |
|
|
2020
Q2 | $67.8M | Buy |
2,072,084
+712,550
| +52% | +$23.3M | 0.08% | 254 |
|
|
2020
Q1 | $40.9M | Sell |
1,359,534
-1,901,444
| -58% | -$57.2M | 0.07% | 258 |
|
|
2019
Q4 | $94.4M | Buy |
3,260,978
+904,688
| +38% | +$26.2M | 0.11% | 186 |
|
|
2019
Q3 | $60.9M | Sell |
2,356,290
-1,447,362
| -38% | -$37.4M | 0.09% | 237 |
|
|
2019
Q2 | $97.1M | Buy |
3,803,652
+1,928,728
| +103% | +$49.2M | 0.08% | 192 |
|
|
2019
Q1 | $49M | Buy |
+1,874,924
| New | +$49M | 0.07% | 285 |
|